Innate Pharma SA ((FR:IPH)) has provided an update. Innate Pharma has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 13-16, 2025, in San Francisco. This participation, including a presentation by CEO Jonathan Dickinson and other executiv...
Healthcare Consumer Utilities Financials Industrials Stock Comparison Tools FAANG Stocks Gold ETFs Cash Equivalents Big Bank Stocks Big Pharma Stocks Retail Stocks Top Indexes Dow Jones S&P 500 Nasdaq Gold Bitcoin Market Outlook Today's Market US Economy Gold & Precious Metals Commodities Forex Editors...
Ascentage Pharma announced that its Chairman and CEO, Dr. Dajun Yang, has accepted an invitation to speak at the 41st Annual J.P. Morgan Healthcare Conference, at 08:30 AM, January 11, 2023, Pacific Time, to provide an update on Ascentage Pharma’s progress with ...
Astellas Pharma Europe Ltd.Astellas Pharma Europe BVMerck Sharp & Dohme Corp. + [2] 最高研发阶段批准上市 首次获批日期 美国(2011-05-27), 梭菌感染腹泻 最高研发阶段(中国)- 特殊审评快速通道 (美国)、孤儿药 (美国)、优先审评 (美国)
1 - 24 Employees Company types CMO/CDMO More Products fromINPHARMA S.p.A.(4) ProductSachet ProductSoftgel Frequently Viewed Together Product0.4 ) Biotin Tablets Application: - · Regulates blood sugar levels · Promotes brain functioning · Protects from heart diseases Therapeutic Indication: - ·...
Big Pharma Stocks Retail Stocks Top Indexes Dow Jones S&P 500 Nasdaq Gold Bitcoin Market Outlook Today's Market US Economy Gold & Precious Metals Commodities Forex Editors' Picks Cryptocurrency Market Data Bond ETFs Commodity ETFs Country ETFs ...
Presentation atJ.P. Morgan Healthcare ConferenceonMonday, January 9th A live webcast of the event will be available via the Investors & News section of theAscendis Pharmawebsite athttps://investors.ascendispharma.com. The presentation will begin at12:00 p.m. Eastern Tim...
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer of Recludix, will ...
ENCell, a Korean company specializing in cell and gene therapy CDMO services, said Monday that it will attend the 43rd J.P. Morgan Healthcare Conference in San Francisco, California, from next Monday to Jan. 16, marking the start of its global partnering efforts. ...
When the health care industry unites, the world can benefit. Deloitte is bringing together leaders to help drive the future of health during our events concurrent to the conference from January 13–15 in San Francisco. We’ll share life sciences and health care M&A insights, discuss key industr...